Target (CBDY) Other Non-Current Assets (2018 - 2026)
Target (CBDY) reported Other Non-Current Assets of $8250.0 for Q1 2026, up 3.12% year-over-year from $8000.0 in Q1 2025, and down 1.67% quarter-over-quarter from $8390.0 in Q4 2025.
Target (CBDY) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Target (CBDY) has 9 years of Other Non-Current Assets data on file, last reported at $8250.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $8250.0, up 3.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $8250.0 (up 3.12% YoY), and the FY2025 annual result was $8390.0, up 4.98% from the prior year.
- Other Non-Current Assets slipped to $8250.0 in Q1 2026 per CBDY's latest filing, from $8390.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $9204.0 in Q1 2022 and troughed at $7992.0 in Q4 2024.
- A 5-year average of $8478.0 and a median of $8488.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets decreased 8.1% in 2024, then gained 4.98% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $8490.0 in 2022, then grew by 2.43% to $8696.0 in 2023, then declined by 8.1% to $7992.0 in 2024, then rose by 4.98% to $8390.0 in 2025, then fell by 1.67% to $8250.0 in 2026.
- Business Quant data shows CBDY's Other Non-Current Assets at $8250.0 in Q1 2026, $8390.0 in Q4 2025, and $8260.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Target | - | - | 191,787.00 | 8,250.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,250.00 |
| Dec 31, 2025 | 8,390.00 |
| Sep 30, 2025 | 8,260.00 |
| Jun 30, 2025 | 8,430.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 7,992.00 |
| Sep 30, 2024 | 8,520.00 |
| Jun 30, 2024 | 8,402.00 |
| Mar 31, 2024 | 8,488.00 |
| Dec 31, 2023 | 8,696.00 |
| Sep 30, 2023 | 8,506.00 |
| Jun 30, 2023 | 8,686.00 |
| Mar 31, 2023 | 8,498.00 |
| Dec 31, 2022 | 8,490.00 |
| Sep 30, 2022 | 8,390.00 |
| Jun 30, 2022 | 8,924.00 |
| Mar 31, 2022 | 9,204.00 |
| Dec 31, 2021 | 9,072.00 |
| Sep 30, 2021 | 9,026.00 |
| Jun 30, 2021 | 9,278.00 |